A new Alzheimer's treatment may be able to remove proteins associated with cognitive decline related to the age-related brain disease, a new study finds. Researchers from the NYU Grossman School of Medicine found that elderly monkeys given a new drug saw a decrease of amyloid beta plaques and tau tangles by up to 59 percent. The treatment 'swallows' the amyloid beta proteins that clog nerve cells and cause cognitive decline ...